NCT03620032View on ClinicalTrials.gov

Study of Re-irradiation at Relapse Versus RT and Multiple Elective rt Courses

PHASE2Active, not recruitingINTERVENTIONAL
Enrollment

54

Participants

Timeline

Start Date

November 2, 2015

Primary Completion Date

November 11, 2022

Study Completion Date

November 2, 2024

Conditions
Diffuse Intrinsic Pontine Glioma
Interventions
DRUG

Nimotuzumab

humanized therapeutic monoclonal antibody against epidermal growth factor receptor (EGFR)

DRUG

Vinorelbine

Chemotherapy

OTHER

Radiotherapy

RADIOTHERAPY SCHEDULE IS DESCRIBED FOR BOTH GROUPS IN THE PERAGRAPH TITLET ARMS

Trial Locations (1)

20133

Fondazione IRCCS Istituto Nazionale Tumori, Milan

All Listed Sponsors
collaborator

University of Roma La Sapienza

OTHER

collaborator

Johannes Gutenberg University Mainz

OTHER

collaborator

Fondazione IRCCS Ca' Granda, Ospedale Maggiore Policlinico

OTHER

collaborator

Wuerzburg University Hospital

OTHER

lead

Fondazione IRCCS Istituto Nazionale dei Tumori, Milano

OTHER